RachelWLinnemannMD

Attending Physician, Children’s Healthcare of Atlanta Associate Professor, Emory University School of Medicine

Dr. Linnemann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1400 Tullie Rd NE
Fl 5
Atlanta, GA 30329
Phone+1 404-785-5437

Fax+1 404-785-9087

Pragmatic Implementation Trial of a CF Primary Palliative Care Intervention Start of enrollment: 2021 Jun 25
Active, not recruiting
Not Applicable
Roles: Contact, Principal Investigator
Trikafta in Cystic Fibrosis Patients Start of enrollment: 2019 Sep 04
Recruiting
Phase 2
Roles: Contact

PubMed

22 citations
EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS.
Tim Lee, Gregory S Sawicki, Josje Altenburg, Stefanie J Millar, Jessica Morlando Geiger
Journal of Cystic Fibrosis. 2023-05-01
2 citations
Development of a Cystic Fibrosis Primary Palliative Care Intervention: Qualitative Analysis of Patient and Family Caregiver Preferences.
Melissa J Basile, Lara Dhingra, Stephanie DiFiglia, Jennifer Polo, Russell Portenoy
Journal of Patient Experience. 2023-01-01
5 citations
Serum anti-PAD4 autoantibodies are present in cystic fibrosis children and increase with age and lung disease severity.
Rachel W Linnemann, Ruchi Yadav, Chao Zhang, Demba Sarr, Balázs Rada
Autoimmunity. 2022-03-01

Children’s Healthcare of Atlanta and Emory University Cystic Fibrosis Care Center Receives Cystic Fibrosis Foundation’s 2024 Outstanding Care Center Partnership AwardNovember 26th, 2024
Transition Planning for Chronic Illnesses in the Time of COVID-19December 3rd, 2020